Komal Patel is an Associate Director at Experic, leading formulation and process development for Orally Inhaled and Nasal Drug Products (OINDP), with a specialized focus on Dry Powder Inhalers (DPI). He also oversees validation activities, ensuring equipment qualification, cleanroom compliance, and adherence to regulatory standards and cGMP guidelines.With over 12 years of industry experience, Komal has driven early to late-stage development across a diverse range of formulations, including inhalation, nasal, oral, topical, and sterile drug products. His expertise in CMC product development spans the entire drug development lifecycle, covering formulation design, device selection, scale-up, and patent litigation for inhalation products.Previously, at Kenox and Amneal Pharmaceuticals, he played a key role in developing nasal sprays, nebulizers, dry powder inhalers, metered dose inhalers, and soft mist inhalers for both 505(b)(2) and NCEs (small and large molecules). Komal has also authored comprehensive CMC sections for multiple inhalation products, supporting their clinical and commercial approvals, while maintaining direct engagement with regulatory agencies such as EMEA, USFDA, and HPRA.